Kairos Ventures invests in ideas, patents, and businesses from top universities and scientists. The firm focuses on early-stage investments, primarily participating in seed and Series A rounds, with occasional involvement in later stages. Kairos targets scientific and technological innovations with the potential to create significant impact across various sectors.
Notable portfolio companies include Provivi, Axial Therapeutics, and Vivodyne. Kairos Ventures provides support to entrepreneurs and scientists, helping them transition from laboratory research to commercial ventures. The firm's team comprises experienced entrepreneurs with diverse business backgrounds, offering valuable expertise to portfolio companies as they develop groundbreaking technologies and solutions.
Kairos Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Total Investments39
Current Portfolio Count28
Total Portfolio Exits1
Top Investment Stages
Seed16 (43.2%)
Series A13 (35.1%)
Series B4 (10.8%)
Series C2 (5.4%)
Series Unknown2 (5.4%)
Stage Mix
Seed 43%Series A 35%Series B 11%Series C 5%Series Unknown 5%
Concentration shown as share of disclosed investments by stage.
Kairos Ventures - Classification
- Also Known As
- Kairos Venture Investments, LLC
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 6720Investment Offices
- 6722Management Investment Offices, Open-end